OrthoPharma and its Swiss client Polymed have launched an open, multicenter, doctor-led study. The research is being conducted by Polymed in cooperation with its network of physicians. About 150 people will be monitored during Stage 1 (dieting stage of 27 days) and Stage 2 (stabilization of 21 days) of the Momentum programme. Results have been received from 88 participants. This is an interim report of the most important fi ndings.